nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—Cystitis—Risedronate—Paget's disease of bone	0.00627	0.00627	CcSEcCtD
Naratriptan—Gastritis—Etidronic acid—Paget's disease of bone	0.0061	0.0061	CcSEcCtD
Naratriptan—Pain—Tiludronate—Paget's disease of bone	0.00605	0.00605	CcSEcCtD
Naratriptan—Dry eye—Risedronate—Paget's disease of bone	0.006	0.006	CcSEcCtD
Naratriptan—Asthma—Etidronic acid—Paget's disease of bone	0.00596	0.00596	CcSEcCtD
Naratriptan—Oesophagitis—Risedronate—Paget's disease of bone	0.00593	0.00593	CcSEcCtD
Naratriptan—Bone pain—Zoledronate—Paget's disease of bone	0.00588	0.00588	CcSEcCtD
Naratriptan—Bladder pain—Risedronate—Paget's disease of bone	0.00587	0.00587	CcSEcCtD
Naratriptan—Inflammation—Zoledronate—Paget's disease of bone	0.00581	0.00581	CcSEcCtD
Naratriptan—Dry skin—Alendronate—Paget's disease of bone	0.00538	0.00538	CcSEcCtD
Naratriptan—Gastroenteritis—Risedronate—Paget's disease of bone	0.00532	0.00532	CcSEcCtD
Naratriptan—Cramp muscle—Alendronate—Paget's disease of bone	0.00529	0.00529	CcSEcCtD
Naratriptan—Neuropathy peripheral—Etidronic acid—Paget's disease of bone	0.00521	0.00521	CcSEcCtD
Naratriptan—Gastritis—Alendronate—Paget's disease of bone	0.0052	0.0052	CcSEcCtD
Naratriptan—Oesophagitis—Zoledronate—Paget's disease of bone	0.00515	0.00515	CcSEcCtD
Naratriptan—Swelling—Pamidronate—Paget's disease of bone	0.00508	0.00508	CcSEcCtD
Naratriptan—Asthma—Alendronate—Paget's disease of bone	0.00508	0.00508	CcSEcCtD
Naratriptan—Asthenia—Tiludronate—Paget's disease of bone	0.00507	0.00507	CcSEcCtD
Naratriptan—Abdominal discomfort—Alendronate—Paget's disease of bone	0.00487	0.00487	CcSEcCtD
Naratriptan—Diarrhoea—Tiludronate—Paget's disease of bone	0.00484	0.00484	CcSEcCtD
Naratriptan—Hallucination—Etidronic acid—Paget's disease of bone	0.00474	0.00474	CcSEcCtD
Naratriptan—Atrial fibrillation—Pamidronate—Paget's disease of bone	0.00473	0.00473	CcSEcCtD
Naratriptan—Sleep disorder—Zoledronate—Paget's disease of bone	0.00473	0.00473	CcSEcCtD
Naratriptan—Dizziness—Tiludronate—Paget's disease of bone	0.00468	0.00468	CcSEcCtD
Naratriptan—Swelling—Zoledronate—Paget's disease of bone	0.00464	0.00464	CcSEcCtD
Naratriptan—Photosensitivity reaction—Alendronate—Paget's disease of bone	0.00463	0.00463	CcSEcCtD
Naratriptan—Anaphylactoid reaction—Pamidronate—Paget's disease of bone	0.00463	0.00463	CcSEcCtD
Naratriptan—Eye pain—Zoledronate—Paget's disease of bone	0.00453	0.00453	CcSEcCtD
Naratriptan—Headache—Tiludronate—Paget's disease of bone	0.00443	0.00443	CcSEcCtD
Naratriptan—Liver function test abnormal—Risedronate—Paget's disease of bone	0.00435	0.00435	CcSEcCtD
Naratriptan—Atrial fibrillation—Zoledronate—Paget's disease of bone	0.00432	0.00432	CcSEcCtD
Naratriptan—Thirst—Zoledronate—Paget's disease of bone	0.0043	0.0043	CcSEcCtD
Naratriptan—Alopecia—Etidronic acid—Paget's disease of bone	0.00421	0.00421	CcSEcCtD
Naratriptan—Nausea—Tiludronate—Paget's disease of bone	0.0042	0.0042	CcSEcCtD
Naratriptan—Gastritis—Risedronate—Paget's disease of bone	0.00417	0.00417	CcSEcCtD
Naratriptan—Erythema—Etidronic acid—Paget's disease of bone	0.00415	0.00415	CcSEcCtD
Naratriptan—Liver function test abnormal—Pamidronate—Paget's disease of bone	0.00414	0.00414	CcSEcCtD
Naratriptan—Haemoglobin—Alendronate—Paget's disease of bone	0.00408	0.00408	CcSEcCtD
Naratriptan—Asthma—Risedronate—Paget's disease of bone	0.00407	0.00407	CcSEcCtD
Naratriptan—Haemorrhage—Alendronate—Paget's disease of bone	0.00406	0.00406	CcSEcCtD
Naratriptan—Cramp muscle—Pamidronate—Paget's disease of bone	0.00403	0.00403	CcSEcCtD
Naratriptan—Muscle spasms—Etidronic acid—Paget's disease of bone	0.00399	0.00399	CcSEcCtD
Naratriptan—Angina pectoris—Risedronate—Paget's disease of bone	0.00397	0.00397	CcSEcCtD
Naratriptan—Gastritis—Pamidronate—Paget's disease of bone	0.00396	0.00396	CcSEcCtD
Naratriptan—Bronchitis—Risedronate—Paget's disease of bone	0.00392	0.00392	CcSEcCtD
Naratriptan—Abdominal discomfort—Risedronate—Paget's disease of bone	0.0039	0.0039	CcSEcCtD
Naratriptan—Anaemia—Etidronic acid—Paget's disease of bone	0.00384	0.00384	CcSEcCtD
Naratriptan—Dehydration—Zoledronate—Paget's disease of bone	0.0038	0.0038	CcSEcCtD
Naratriptan—Cramp muscle—Zoledronate—Paget's disease of bone	0.00368	0.00368	CcSEcCtD
Naratriptan—Pneumonia—Risedronate—Paget's disease of bone	0.00365	0.00365	CcSEcCtD
Naratriptan—Gastritis—Zoledronate—Paget's disease of bone	0.00362	0.00362	CcSEcCtD
Naratriptan—Depression—Risedronate—Paget's disease of bone	0.00362	0.00362	CcSEcCtD
Naratriptan—Alopecia—Alendronate—Paget's disease of bone	0.00359	0.00359	CcSEcCtD
Naratriptan—Erythema—Alendronate—Paget's disease of bone	0.00354	0.00354	CcSEcCtD
Naratriptan—Asthma—Zoledronate—Paget's disease of bone	0.00354	0.00354	CcSEcCtD
Naratriptan—Arthralgia—Etidronic acid—Paget's disease of bone	0.00353	0.00353	CcSEcCtD
Naratriptan—Discomfort—Etidronic acid—Paget's disease of bone	0.00349	0.00349	CcSEcCtD
Naratriptan—Pneumonia—Pamidronate—Paget's disease of bone	0.00347	0.00347	CcSEcCtD
Naratriptan—Confusional state—Etidronic acid—Paget's disease of bone	0.00342	0.00342	CcSEcCtD
Naratriptan—Sinusitis—Risedronate—Paget's disease of bone	0.00341	0.00341	CcSEcCtD
Naratriptan—Muscle spasms—Alendronate—Paget's disease of bone	0.0034	0.0034	CcSEcCtD
Naratriptan—Abdominal discomfort—Zoledronate—Paget's disease of bone	0.00339	0.00339	CcSEcCtD
Naratriptan—Infection—Etidronic acid—Paget's disease of bone	0.00337	0.00337	CcSEcCtD
Naratriptan—Ill-defined disorder—Alendronate—Paget's disease of bone	0.00328	0.00328	CcSEcCtD
Naratriptan—Haemoglobin—Risedronate—Paget's disease of bone	0.00328	0.00328	CcSEcCtD
Naratriptan—Anaemia—Alendronate—Paget's disease of bone	0.00327	0.00327	CcSEcCtD
Naratriptan—Pollakiuria—Zoledronate—Paget's disease of bone	0.00327	0.00327	CcSEcCtD
Naratriptan—Haemorrhage—Risedronate—Paget's disease of bone	0.00326	0.00326	CcSEcCtD
Naratriptan—Sinusitis—Pamidronate—Paget's disease of bone	0.00324	0.00324	CcSEcCtD
Naratriptan—Malaise—Alendronate—Paget's disease of bone	0.00319	0.00319	CcSEcCtD
Naratriptan—Vertigo—Alendronate—Paget's disease of bone	0.00318	0.00318	CcSEcCtD
Naratriptan—Depression—Zoledronate—Paget's disease of bone	0.00314	0.00314	CcSEcCtD
Naratriptan—Haemoglobin—Pamidronate—Paget's disease of bone	0.00311	0.00311	CcSEcCtD
Naratriptan—Haemorrhage—Pamidronate—Paget's disease of bone	0.0031	0.0031	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00309	0.00309	CcSEcCtD
Naratriptan—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00304	0.00304	CcSEcCtD
Naratriptan—Tinnitus—Risedronate—Paget's disease of bone	0.00304	0.00304	CcSEcCtD
Naratriptan—Cardiac disorder—Risedronate—Paget's disease of bone	0.00303	0.00303	CcSEcCtD
Naratriptan—Myalgia—Alendronate—Paget's disease of bone	0.00301	0.00301	CcSEcCtD
Naratriptan—Discomfort—Alendronate—Paget's disease of bone	0.00297	0.00297	CcSEcCtD
Naratriptan—Angiopathy—Risedronate—Paget's disease of bone	0.00296	0.00296	CcSEcCtD
Naratriptan—Immune system disorder—Risedronate—Paget's disease of bone	0.00294	0.00294	CcSEcCtD
Naratriptan—Arrhythmia—Risedronate—Paget's disease of bone	0.00291	0.00291	CcSEcCtD
Naratriptan—Constipation—Etidronic acid—Paget's disease of bone	0.0029	0.0029	CcSEcCtD
Naratriptan—Bradycardia—Zoledronate—Paget's disease of bone	0.00288	0.00288	CcSEcCtD
Naratriptan—Cardiac disorder—Pamidronate—Paget's disease of bone	0.00288	0.00288	CcSEcCtD
Naratriptan—Infection—Alendronate—Paget's disease of bone	0.00287	0.00287	CcSEcCtD
Naratriptan—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.00282	0.00282	CcSEcCtD
Naratriptan—Angiopathy—Pamidronate—Paget's disease of bone	0.00281	0.00281	CcSEcCtD
Naratriptan—Immune system disorder—Pamidronate—Paget's disease of bone	0.0028	0.0028	CcSEcCtD
Naratriptan—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.00279	0.00279	CcSEcCtD
Naratriptan—Chills—Pamidronate—Paget's disease of bone	0.00278	0.00278	CcSEcCtD
Naratriptan—Alopecia—Pamidronate—Paget's disease of bone	0.00274	0.00274	CcSEcCtD
Naratriptan—Muscle spasms—Risedronate—Paget's disease of bone	0.00273	0.00273	CcSEcCtD
Naratriptan—Erythema—Pamidronate—Paget's disease of bone	0.0027	0.0027	CcSEcCtD
Naratriptan—Urticaria—Etidronic acid—Paget's disease of bone	0.00269	0.00269	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00263	0.00263	CcSEcCtD
Naratriptan—Cardiac disorder—Zoledronate—Paget's disease of bone	0.00263	0.00263	CcSEcCtD
Naratriptan—Anaemia—Risedronate—Paget's disease of bone	0.00262	0.00262	CcSEcCtD
Naratriptan—Muscle spasms—Pamidronate—Paget's disease of bone	0.00259	0.00259	CcSEcCtD
Naratriptan—Angiopathy—Zoledronate—Paget's disease of bone	0.00257	0.00257	CcSEcCtD
Naratriptan—Immune system disorder—Zoledronate—Paget's disease of bone	0.00256	0.00256	CcSEcCtD
Naratriptan—Vertigo—Risedronate—Paget's disease of bone	0.00255	0.00255	CcSEcCtD
Naratriptan—Syncope—Risedronate—Paget's disease of bone	0.00254	0.00254	CcSEcCtD
Naratriptan—Chills—Zoledronate—Paget's disease of bone	0.00254	0.00254	CcSEcCtD
Naratriptan—Arrhythmia—Zoledronate—Paget's disease of bone	0.00253	0.00253	CcSEcCtD
Naratriptan—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.0025	0.0025	CcSEcCtD
Naratriptan—Alopecia—Zoledronate—Paget's disease of bone	0.0025	0.0025	CcSEcCtD
Naratriptan—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.0025	0.0025	CcSEcCtD
Naratriptan—Loss of consciousness—Risedronate—Paget's disease of bone	0.00249	0.00249	CcSEcCtD
Naratriptan—Anaemia—Pamidronate—Paget's disease of bone	0.00249	0.00249	CcSEcCtD
Naratriptan—Agitation—Pamidronate—Paget's disease of bone	0.00248	0.00248	CcSEcCtD
Naratriptan—Cough—Risedronate—Paget's disease of bone	0.00248	0.00248	CcSEcCtD
Naratriptan—Constipation—Alendronate—Paget's disease of bone	0.00247	0.00247	CcSEcCtD
Naratriptan—Pain—Alendronate—Paget's disease of bone	0.00247	0.00247	CcSEcCtD
Naratriptan—Erythema—Zoledronate—Paget's disease of bone	0.00246	0.00246	CcSEcCtD
Naratriptan—Malaise—Pamidronate—Paget's disease of bone	0.00243	0.00243	CcSEcCtD
Naratriptan—Syncope—Pamidronate—Paget's disease of bone	0.00242	0.00242	CcSEcCtD
Naratriptan—Myalgia—Risedronate—Paget's disease of bone	0.00242	0.00242	CcSEcCtD
Naratriptan—Arthralgia—Risedronate—Paget's disease of bone	0.00242	0.00242	CcSEcCtD
Naratriptan—Anxiety—Risedronate—Paget's disease of bone	0.00241	0.00241	CcSEcCtD
Naratriptan—Pruritus—Etidronic acid—Paget's disease of bone	0.0024	0.0024	CcSEcCtD
Naratriptan—Feeling abnormal—Alendronate—Paget's disease of bone	0.00238	0.00238	CcSEcCtD
Naratriptan—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00237	0.00237	CcSEcCtD
Naratriptan—Muscle spasms—Zoledronate—Paget's disease of bone	0.00237	0.00237	CcSEcCtD
Naratriptan—Dry mouth—Risedronate—Paget's disease of bone	0.00236	0.00236	CcSEcCtD
Naratriptan—Cough—Pamidronate—Paget's disease of bone	0.00235	0.00235	CcSEcCtD
Naratriptan—Convulsion—Pamidronate—Paget's disease of bone	0.00234	0.00234	CcSEcCtD
Naratriptan—Vision blurred—Zoledronate—Paget's disease of bone	0.00232	0.00232	CcSEcCtD
Naratriptan—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00232	0.00232	CcSEcCtD
Naratriptan—Tremor—Zoledronate—Paget's disease of bone	0.00231	0.00231	CcSEcCtD
Naratriptan—Infection—Risedronate—Paget's disease of bone	0.0023	0.0023	CcSEcCtD
Naratriptan—Myalgia—Pamidronate—Paget's disease of bone	0.0023	0.0023	CcSEcCtD
Naratriptan—Arthralgia—Pamidronate—Paget's disease of bone	0.0023	0.0023	CcSEcCtD
Naratriptan—Urticaria—Alendronate—Paget's disease of bone	0.00229	0.00229	CcSEcCtD
Naratriptan—Anxiety—Pamidronate—Paget's disease of bone	0.00229	0.00229	CcSEcCtD
Naratriptan—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.00229	0.00229	CcSEcCtD
Naratriptan—Body temperature increased—Alendronate—Paget's disease of bone	0.00228	0.00228	CcSEcCtD
Naratriptan—Shock—Risedronate—Paget's disease of bone	0.00228	0.00228	CcSEcCtD
Naratriptan—Anaemia—Zoledronate—Paget's disease of bone	0.00228	0.00228	CcSEcCtD
Naratriptan—Nervous system disorder—Risedronate—Paget's disease of bone	0.00227	0.00227	CcSEcCtD
Naratriptan—Discomfort—Pamidronate—Paget's disease of bone	0.00227	0.00227	CcSEcCtD
Naratriptan—Agitation—Zoledronate—Paget's disease of bone	0.00226	0.00226	CcSEcCtD
Naratriptan—Skin disorder—Risedronate—Paget's disease of bone	0.00225	0.00225	CcSEcCtD
Naratriptan—Malaise—Zoledronate—Paget's disease of bone	0.00222	0.00222	CcSEcCtD
Naratriptan—Confusional state—Pamidronate—Paget's disease of bone	0.00222	0.00222	CcSEcCtD
Naratriptan—Vertigo—Zoledronate—Paget's disease of bone	0.00221	0.00221	CcSEcCtD
Naratriptan—Syncope—Zoledronate—Paget's disease of bone	0.00221	0.00221	CcSEcCtD
Naratriptan—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.0022	0.0022	CcSEcCtD
Naratriptan—Oedema—Pamidronate—Paget's disease of bone	0.0022	0.0022	CcSEcCtD
Naratriptan—Infection—Pamidronate—Paget's disease of bone	0.00219	0.00219	CcSEcCtD
Naratriptan—Palpitations—Zoledronate—Paget's disease of bone	0.00218	0.00218	CcSEcCtD
Naratriptan—Shock—Pamidronate—Paget's disease of bone	0.00217	0.00217	CcSEcCtD
Naratriptan—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00217	0.00217	CcSEcCtD
Naratriptan—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00216	0.00216	CcSEcCtD
Naratriptan—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.00216	0.00216	CcSEcCtD
Naratriptan—Vomiting—Etidronic acid—Paget's disease of bone	0.00215	0.00215	CcSEcCtD
Naratriptan—Cough—Zoledronate—Paget's disease of bone	0.00215	0.00215	CcSEcCtD
Naratriptan—Rash—Etidronic acid—Paget's disease of bone	0.00214	0.00214	CcSEcCtD
Naratriptan—Convulsion—Zoledronate—Paget's disease of bone	0.00213	0.00213	CcSEcCtD
Naratriptan—Dermatitis—Etidronic acid—Paget's disease of bone	0.00213	0.00213	CcSEcCtD
Naratriptan—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.00213	0.00213	CcSEcCtD
Naratriptan—Hypersensitivity—Alendronate—Paget's disease of bone	0.00213	0.00213	CcSEcCtD
Naratriptan—Headache—Etidronic acid—Paget's disease of bone	0.00212	0.00212	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00211	0.00211	CcSEcCtD
Naratriptan—Arthralgia—Zoledronate—Paget's disease of bone	0.0021	0.0021	CcSEcCtD
Naratriptan—Myalgia—Zoledronate—Paget's disease of bone	0.0021	0.0021	CcSEcCtD
Naratriptan—Anxiety—Zoledronate—Paget's disease of bone	0.00209	0.00209	CcSEcCtD
Naratriptan—Paraesthesia—Risedronate—Paget's disease of bone	0.00208	0.00208	CcSEcCtD
Naratriptan—Discomfort—Zoledronate—Paget's disease of bone	0.00207	0.00207	CcSEcCtD
Naratriptan—Asthenia—Alendronate—Paget's disease of bone	0.00207	0.00207	CcSEcCtD
Naratriptan—Dyspnoea—Risedronate—Paget's disease of bone	0.00206	0.00206	CcSEcCtD
Naratriptan—Hypotension—Pamidronate—Paget's disease of bone	0.00206	0.00206	CcSEcCtD
Naratriptan—Dry mouth—Zoledronate—Paget's disease of bone	0.00205	0.00205	CcSEcCtD
Naratriptan—Pruritus—Alendronate—Paget's disease of bone	0.00204	0.00204	CcSEcCtD
Naratriptan—Confusional state—Zoledronate—Paget's disease of bone	0.00203	0.00203	CcSEcCtD
Naratriptan—Nausea—Etidronic acid—Paget's disease of bone	0.00201	0.00201	CcSEcCtD
Naratriptan—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.00201	0.00201	CcSEcCtD
Naratriptan—Oedema—Zoledronate—Paget's disease of bone	0.00201	0.00201	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.00201	0.00201	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.002	0.002	CcSEcCtD
Naratriptan—Infection—Zoledronate—Paget's disease of bone	0.002	0.002	CcSEcCtD
Naratriptan—Fatigue—Risedronate—Paget's disease of bone	0.002	0.002	CcSEcCtD
Naratriptan—Pain—Risedronate—Paget's disease of bone	0.00198	0.00198	CcSEcCtD
Naratriptan—Constipation—Risedronate—Paget's disease of bone	0.00198	0.00198	CcSEcCtD
Naratriptan—Shock—Zoledronate—Paget's disease of bone	0.00198	0.00198	CcSEcCtD
Naratriptan—Paraesthesia—Pamidronate—Paget's disease of bone	0.00198	0.00198	CcSEcCtD
Naratriptan—Diarrhoea—Alendronate—Paget's disease of bone	0.00197	0.00197	CcSEcCtD
Naratriptan—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00197	0.00197	CcSEcCtD
Naratriptan—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.00197	0.00197	CcSEcCtD
Naratriptan—Dyspnoea—Pamidronate—Paget's disease of bone	0.00196	0.00196	CcSEcCtD
Naratriptan—Somnolence—Pamidronate—Paget's disease of bone	0.00196	0.00196	CcSEcCtD
Naratriptan—Skin disorder—Zoledronate—Paget's disease of bone	0.00195	0.00195	CcSEcCtD
Naratriptan—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.00194	0.00194	CcSEcCtD
Naratriptan—Dizziness—Alendronate—Paget's disease of bone	0.00191	0.00191	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.0019	0.0019	CcSEcCtD
Naratriptan—Fatigue—Pamidronate—Paget's disease of bone	0.0019	0.0019	CcSEcCtD
Naratriptan—Pain—Pamidronate—Paget's disease of bone	0.00188	0.00188	CcSEcCtD
Naratriptan—Constipation—Pamidronate—Paget's disease of bone	0.00188	0.00188	CcSEcCtD
Naratriptan—Hypotension—Zoledronate—Paget's disease of bone	0.00188	0.00188	CcSEcCtD
Naratriptan—Urticaria—Risedronate—Paget's disease of bone	0.00184	0.00184	CcSEcCtD
Naratriptan—Vomiting—Alendronate—Paget's disease of bone	0.00184	0.00184	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00183	0.00183	CcSEcCtD
Naratriptan—Body temperature increased—Risedronate—Paget's disease of bone	0.00183	0.00183	CcSEcCtD
Naratriptan—Rash—Alendronate—Paget's disease of bone	0.00182	0.00182	CcSEcCtD
Naratriptan—Dermatitis—Alendronate—Paget's disease of bone	0.00182	0.00182	CcSEcCtD
Naratriptan—Feeling abnormal—Pamidronate—Paget's disease of bone	0.00181	0.00181	CcSEcCtD
Naratriptan—Headache—Alendronate—Paget's disease of bone	0.00181	0.00181	CcSEcCtD
Naratriptan—Paraesthesia—Zoledronate—Paget's disease of bone	0.00181	0.00181	CcSEcCtD
Naratriptan—Dyspnoea—Zoledronate—Paget's disease of bone	0.00179	0.00179	CcSEcCtD
Naratriptan—Somnolence—Zoledronate—Paget's disease of bone	0.00179	0.00179	CcSEcCtD
Naratriptan—Body temperature increased—Pamidronate—Paget's disease of bone	0.00174	0.00174	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00174	0.00174	CcSEcCtD
Naratriptan—Fatigue—Zoledronate—Paget's disease of bone	0.00173	0.00173	CcSEcCtD
Naratriptan—Constipation—Zoledronate—Paget's disease of bone	0.00172	0.00172	CcSEcCtD
Naratriptan—Pain—Zoledronate—Paget's disease of bone	0.00172	0.00172	CcSEcCtD
Naratriptan—Nausea—Alendronate—Paget's disease of bone	0.00171	0.00171	CcSEcCtD
Naratriptan—Hypersensitivity—Risedronate—Paget's disease of bone	0.00171	0.00171	CcSEcCtD
Naratriptan—Asthenia—Risedronate—Paget's disease of bone	0.00166	0.00166	CcSEcCtD
Naratriptan—Feeling abnormal—Zoledronate—Paget's disease of bone	0.00166	0.00166	CcSEcCtD
Naratriptan—Pruritus—Risedronate—Paget's disease of bone	0.00164	0.00164	CcSEcCtD
Naratriptan—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00162	0.00162	CcSEcCtD
Naratriptan—Urticaria—Zoledronate—Paget's disease of bone	0.0016	0.0016	CcSEcCtD
Naratriptan—Body temperature increased—Zoledronate—Paget's disease of bone	0.00159	0.00159	CcSEcCtD
Naratriptan—Diarrhoea—Risedronate—Paget's disease of bone	0.00158	0.00158	CcSEcCtD
Naratriptan—Asthenia—Pamidronate—Paget's disease of bone	0.00158	0.00158	CcSEcCtD
Naratriptan—Pruritus—Pamidronate—Paget's disease of bone	0.00156	0.00156	CcSEcCtD
Naratriptan—Dizziness—Risedronate—Paget's disease of bone	0.00153	0.00153	CcSEcCtD
Naratriptan—Diarrhoea—Pamidronate—Paget's disease of bone	0.00151	0.00151	CcSEcCtD
Naratriptan—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00148	0.00148	CcSEcCtD
Naratriptan—Vomiting—Risedronate—Paget's disease of bone	0.00147	0.00147	CcSEcCtD
Naratriptan—Rash—Risedronate—Paget's disease of bone	0.00146	0.00146	CcSEcCtD
Naratriptan—Dermatitis—Risedronate—Paget's disease of bone	0.00146	0.00146	CcSEcCtD
Naratriptan—Dizziness—Pamidronate—Paget's disease of bone	0.00146	0.00146	CcSEcCtD
Naratriptan—Headache—Risedronate—Paget's disease of bone	0.00145	0.00145	CcSEcCtD
Naratriptan—Asthenia—Zoledronate—Paget's disease of bone	0.00144	0.00144	CcSEcCtD
Naratriptan—Pruritus—Zoledronate—Paget's disease of bone	0.00142	0.00142	CcSEcCtD
Naratriptan—Vomiting—Pamidronate—Paget's disease of bone	0.0014	0.0014	CcSEcCtD
Naratriptan—Rash—Pamidronate—Paget's disease of bone	0.00139	0.00139	CcSEcCtD
Naratriptan—Dermatitis—Pamidronate—Paget's disease of bone	0.00139	0.00139	CcSEcCtD
Naratriptan—Headache—Pamidronate—Paget's disease of bone	0.00138	0.00138	CcSEcCtD
Naratriptan—Diarrhoea—Zoledronate—Paget's disease of bone	0.00138	0.00138	CcSEcCtD
Naratriptan—Nausea—Risedronate—Paget's disease of bone	0.00138	0.00138	CcSEcCtD
Naratriptan—Dizziness—Zoledronate—Paget's disease of bone	0.00133	0.00133	CcSEcCtD
Naratriptan—Nausea—Pamidronate—Paget's disease of bone	0.00131	0.00131	CcSEcCtD
Naratriptan—Vomiting—Zoledronate—Paget's disease of bone	0.00128	0.00128	CcSEcCtD
Naratriptan—Rash—Zoledronate—Paget's disease of bone	0.00127	0.00127	CcSEcCtD
Naratriptan—Dermatitis—Zoledronate—Paget's disease of bone	0.00127	0.00127	CcSEcCtD
Naratriptan—Headache—Zoledronate—Paget's disease of bone	0.00126	0.00126	CcSEcCtD
Naratriptan—Nausea—Zoledronate—Paget's disease of bone	0.00119	0.00119	CcSEcCtD
